ATE462001T1 - Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit - Google Patents

Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit

Info

Publication number
ATE462001T1
ATE462001T1 AT03786267T AT03786267T ATE462001T1 AT E462001 T1 ATE462001 T1 AT E462001T1 AT 03786267 T AT03786267 T AT 03786267T AT 03786267 T AT03786267 T AT 03786267T AT E462001 T1 ATE462001 T1 AT E462001T1
Authority
AT
Austria
Prior art keywords
liver disease
diagnosing liver
protein
molecular weight
decomposition product
Prior art date
Application number
AT03786267T
Other languages
English (en)
Inventor
Fumio Nomura
Kazuyuki Sogawa
Takeshi Tomonaga
Takenori Ochiai
Hideaki Shimada
Tatsuya Ohashi
Katsuhiro Katayama
Original Assignee
Nitto Boseki Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Boseki Co Ltd filed Critical Nitto Boseki Co Ltd
Application granted granted Critical
Publication of ATE462001T1 publication Critical patent/ATE462001T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Endoscopes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03786267T 2002-12-24 2003-12-24 Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit ATE462001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002371959 2002-12-24
PCT/JP2003/016600 WO2004058966A1 (ja) 2002-12-24 2003-12-24 肝臓疾患診断用マーカー蛋白質およびそれを利用した肝臓疾患診断方法

Publications (1)

Publication Number Publication Date
ATE462001T1 true ATE462001T1 (de) 2010-04-15

Family

ID=32677218

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03786267T ATE462001T1 (de) 2002-12-24 2003-12-24 Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit

Country Status (9)

Country Link
US (2) US7517951B2 (de)
EP (1) EP1577385B1 (de)
JP (1) JP4196948B2 (de)
CN (1) CN100384996C (de)
AT (1) ATE462001T1 (de)
AU (1) AU2003296085A1 (de)
DE (1) DE60331857D1 (de)
NO (1) NO336459B1 (de)
WO (1) WO2004058966A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4597741B2 (ja) * 2005-03-31 2010-12-15 株式会社Mcbi タンパク質、部分タンパク質および／もしくは部分ペプチド、またはそれらのプロファイルに基づく体外診断システム
FR2893136A1 (fr) * 2005-11-10 2007-05-11 Sanofi Aventis Sa Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies
US7750018B2 (en) * 2006-12-06 2010-07-06 Tactical Therapeutics, Inc Use of carboxiamidotriazole (CAI) orotate in macular degeneration
JP5419680B2 (ja) * 2007-02-28 2014-02-19 日東紡績株式会社 アルコール性肝障害診断用マーカーペプチドおよびそれを利用したアルコール性肝障害診断方法
JP2009114092A (ja) * 2007-11-02 2009-05-28 Mcbi:Kk 慢性肝炎、肝硬変、肝がんの分別診断のための新規バイオマーカーおよび該バイオマーカーを用いた慢性肝炎、肝硬変、肝がんの分別診断方法
JP2012501454A (ja) * 2008-08-28 2012-01-19 サルトリア・フアーマシユーテイカルズ・エル・エル・シー 肝臓病学的有害事象のリスクのある患者を同定するためのスクリーニング法
JP2010175452A (ja) * 2009-01-30 2010-08-12 Japan Health Science Foundation 膵臓癌の検出法
WO2011052380A1 (ja) 2009-10-28 2011-05-05 日東紡績株式会社 ５．９ｋＤａペプチドの免疫学的測定方法
CN102507941B (zh) * 2011-10-25 2014-04-30 北京正旦国际科技有限责任公司 一种肝硬化免疫质谱检测试剂盒
CN102507936B (zh) * 2011-11-09 2013-10-23 北京正旦国际科技有限责任公司 一种肝癌标志物多抗免疫质谱试剂盒
CA2856461C (en) * 2011-12-01 2020-08-18 F. Hoffmann-La Roche Ag Nt-proanp and nt-probnp for the diagnosis of stroke
WO2013141092A1 (ja) * 2012-03-21 2013-09-26 Tsuru Michiyo 癌転移マーカー及びそれを用いた癌転移の診断方法
CN109444405A (zh) * 2018-10-10 2019-03-08 东南大学 一种基于荧光预猝灭和表面增强荧光效应的免疫检测方法
CN110157792A (zh) * 2019-04-22 2019-08-23 中山大学孙逸仙纪念医院 血清外泌体has_circ_0004771在制备酒精依赖综合征诊断试剂中的应用
CN116041506B (zh) * 2023-01-05 2023-12-05 深圳上泰生物工程有限公司 糖缺失性转铁蛋白的单克隆抗体对及检测试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63237795A (ja) 1987-03-24 1988-10-04 Otsuka Pharmaceut Factory Inc アポリポタンパク質の製造法
WO1994016085A2 (en) 1992-12-30 1994-07-21 Zymogenetics, Inc. Hybrid proteins having cross-linking and tissue-binding activities
US5639940A (en) * 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
ES2288962T3 (es) * 2000-04-28 2008-02-01 Bayer Aktiengesellschaft Diagnostico de fibrosis hepatica con algoritmos de marcadores sericos.
CN1170943C (zh) * 2000-10-20 2004-10-13 上海医药(集团）总公司 建立载脂蛋白a-i细胞靶标筛药系统及筛选升高密度脂蛋白药的方法
ES2226549B1 (es) * 2002-12-18 2006-07-16 One Way Liver Genomics, S.L. Metodo para el diagnostico de esteatohepatitis no alcoholica (nash) mediante el empleo de marcadores moleculares.

Also Published As

Publication number Publication date
US7781180B2 (en) 2010-08-24
JP4196948B2 (ja) 2008-12-17
EP1577385B1 (de) 2010-03-24
NO20052992L (no) 2005-09-14
CN100384996C (zh) 2008-04-30
DE60331857D1 (de) 2010-05-06
CN1732261A (zh) 2006-02-08
JPWO2004058966A1 (ja) 2006-04-27
NO336459B1 (no) 2015-08-31
WO2004058966A1 (ja) 2004-07-15
US20090275059A1 (en) 2009-11-05
AU2003296085A1 (en) 2004-07-22
US7517951B2 (en) 2009-04-14
EP1577385A1 (de) 2005-09-21
EP1577385A4 (de) 2006-08-23
US20060116504A1 (en) 2006-06-01
NO20052992D0 (no) 2005-06-17

Similar Documents

Publication Publication Date Title
ATE462001T1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE432470T1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DK2275815T3 (da) Forbedrede immunoassay-fremgangsmåder
DK1734368T3 (da) Annexin-autoantistoffer anvendt som markörer for lungecancer
DE60041355D1 (de) Verfahren zur detektion von erkrankungen
DE602004022575D1 (de) Verfahren zum selektiven testen von adiponectinmultimeren
BRPI0112262B8 (pt) processo para detecção e teste para um marcador de uma doença conformacional, kit, processo para identificar um composto, processo para detectar a presença de uma forma patogênica prp sc de proteína de príon, e aparelho
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
EP2287618A3 (de) Verfahren zur Diagnose neurodegenerativer Erkrankungen
DE602004021281D1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE60318987D1 (de) Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE60317379D1 (de) Neurotoxische aminosäure oder neurotoxisches derivat davon im zusammenhang mit neurologischen störungen
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE433463T1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE410679T1 (de) Verfahren zur identifikation von antivirale substanzen
DE60334408D1 (de) Nsäuren
DE60322240D1 (de) Katzenpankreas-lipase-zusammensetzung und verfahren zur herstellung und verwendung einer solchen zusammensetzung
DE60311278D1 (de) Immunochromatographiesystem und verfahren zur gleichzeitigen identifikation von aga-und t-tg-antikörpern und verwendung dafür zur diagnose der zöliakiekrankheit
Chowdhury Analysis of Proteins from Archaeological Artefacts, with a Focus on Ancient Human Diet
DK1210606T3 (da) Bruskresorptionsassays

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties